Background: The prevalence of Parkinson’s disease (PD) increases as the population ages. Studies have shown that some cardiometabolic comorbidities could be associated with risk or protection against developing PD. A retrospective case-control study was carried out to analyze the relationship between PD and cardiometabolic comorbidities. Material and methods: Subjects with PD and controls without PD were consecutively recruited. Data on type 2 diabetes mellitus, systemic arterial hypertension (SAH), dyslipidemia and body mass index were collected. Logistic regression analyses were carried out. Results: A total of 781 subjects with PD (56.5% male) and 1,000 controls (44.4% males) were included. After adjusting for age and gender, SAH was found as an independent risk factor (OR 1.32, CI 95% 1.05-1.67, p=0.02), and obesity a protective factor (OR 0.72, CI 95% 0.56-0.93, p=0.01). Conclusion: Subjects with SAH had an higher risk of having PD. while obese subjects had a lower risk of having PD. The relationship between cardiometabolic disease, its treatment, and PD etiopathogenesis ap-pears to be extremely complex given the amount of contradictory data.
CITATION STYLE
Cervantes-Arriaga, A., Esquivel-Zapata, Ó., Escobar-Valdivia, E., García-Romero, D., Alcocer-Salas, Á., & Rodríguez-Violante, M. (2021). Association between cardiometabolic comorbidities and parkinson’s disease in a mexican population. Gaceta Medica de Mexico, 157(6), 645–650. https://doi.org/10.24875/GMM.21000294
Mendeley helps you to discover research relevant for your work.